查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1738426

维生素 B12 市场 - 全球产业规模、份额、趋势、机会及预测（按销售管道、最终用途、地区和竞争细分，2020-2030 年）

Vitamin B12 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球维生素 B12 市值为 1.6509 亿美元，预计到 2030 年将达到 1.9902 亿美元，复合年增长率为 2.58%。维生素 B12 又称为钴胺素，在红血球生成、神经健康和 DNA 合成中起着至关重要的作用。人们越来越意识到其在预防疲劳、贫血和神经系统疾病方面的重要性，这推动了不同族群补充维生素 B12 的趋势。遵循植物性饮食的人尤其容易缺乏维生素 B12，因此对谷物、能量饮料和植物奶等强化产品的需求不断增长。此外，人口老化导致营养吸收能力下降，进一步刺激了对临床营养解决方案的需求。维生素 B12 在药物和营养保健品配方中的应用日益广泛，凸显了其在健康维护和疾病管理中日益重要的作用，尤其是在认知和疲劳相关疾病方面。

市场概览
预测期 2026-2030
2024年市场规模 1.6509亿美元
2030年市场规模 1.9902亿美元
2025-2030 年复合年增长率 2.58%
成长最快的领域 直接的
最大的市场 北美洲

关键市场驱动因素

製药业的成长

主要市场挑战

生产成本高

主要市场趋势

营养保健品应用的扩展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球维生素 B12 市场的影响

第五章：全球维生素B12市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按销售管道（直接、间接）
    • 依最终用途（製药、动物饲料、食品和饮料、医疗保健、个人护理、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美维生素B12市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲维生素B12市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太维生素B12市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美维生素B12市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲维生素B12市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第 13 章：全球维生素 B12 市场：SWOT 分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Hebei Yuxing Bio-Engineering Co., Ltd.
  • Hebei Huarong Pharmaceutical Co., Ltd
  • North China Pharmaceutical Group Corp. (NCPC)
  • Ningxia Kingvit Pharmaceutical CO.,LTD
  • Euroapi
  • DSM

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 29291

The Global Vitamin B12 Market was valued at USD 165.09 Million in 2024 and is projected to reach USD 199.02 Million by 2030, growing at a CAGR of 2.58%. Known as cobalamin, Vitamin B12 plays an essential role in red blood cell production, nerve health, and DNA synthesis. Rising awareness of its importance in preventing fatigue, anemia, and neurological disorders is driving increased supplementation across various demographic groups. Individuals following plant-based diets are especially at risk for deficiency, resulting in a growing demand for fortified products such as cereals, energy drinks, and plant-based milk. Additionally, an aging population with reduced nutrient absorption capacity further fuels demand for clinical nutrition solutions. The expanding use of Vitamin B12 in pharmaceutical and nutraceutical formulations highlights its evolving role in health maintenance and disease management, particularly for cognitive and fatigue-related conditions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 165.09 Million
Market Size 2030USD 199.02 Million
CAGR 2025-20302.58%
Fastest Growing SegmentDirect
Largest MarketNorth America

Key Market Drivers

Growth in Pharmaceutical Industry

The continued expansion of the pharmaceutical sector is a major growth driver for the Vitamin B12 market. With global pharmaceutical revenues reaching USD 1.6 trillion by 2023, the industry has become a key consumer of Vitamin B12, particularly in applications related to anemia, neurological health, and prenatal care. Vitamin B12 is indispensable for red blood cell formation, nervous system function, and DNA replication, making it a staple ingredient in a variety of pharmaceutical products. Increased awareness about deficiencies-especially among vegetarians, the elderly, and individuals with absorption issues-has further accelerated demand. Companies like EUROAPI, which remains the only Western-based producer of Vitamin B12 for pharmaceutical use, continue to innovate with advanced fermentation technologies to meet global supply needs.

Key Market Challenges

High Production Costs

High production costs present a major challenge in the Vitamin B12 market. Manufacturing bioactive forms like methylcobalamin involves complex microbial fermentation processes and sophisticated purification methods. These procedures require stringent environmental controls and high operational precision, significantly driving up costs. Production yields can vary due to inconsistencies in microbial performance and raw material quality, leading to inefficiencies and wastage. Furthermore, maintaining product purity and stability demands advanced technology and rigorous quality control, particularly in regions with elevated labor and energy costs. These factors make large-scale production costly and reduce profitability for manufacturers, especially smaller enterprises.

Key Market Trends

Expansion of Nutraceutical Applications

The growing popularity of nutraceuticals is a key trend bolstering the Vitamin B12 market. Increasing consumer focus on preventive healthcare and overall wellness is driving demand for Vitamin B12 in functional foods and dietary supplements. In India, for instance, the government introduced fortified nutritional products like Jan Aushadhi Poshan under the PMBJP initiative, containing Vitamin B12 among other vital nutrients. B12's recognized benefits in energy production, cognitive health, and immune support are making it a popular addition to multivitamins, fortified drinks, and meal replacement formulas. With health-conscious lifestyles becoming more prevalent, especially in North America, Europe, and Asia-Pacific, manufacturers are actively expanding their nutraceutical product lines enriched with B12.

Key Market Players

  • Hebei Yuxing Bio-Engineering Co., Ltd.
  • Hebei Huarong Pharmaceutical Co., Ltd
  • North China Pharmaceutical Group Corp. (NCPC)
  • Ningxia Kingvit Pharmaceutical CO., LTD
  • Euroapi
  • DSM

Report Scope

In this report, the Global Vitamin B12 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vitamin B12 Market, By Sales Channel:

  • Direct
  • Indirect

Vitamin B12 Market, By End Use:

  • Pharmaceutical
  • Animal Feed
  • Food & Beverages
  • Healthcare
  • Personal Care
  • Others

Vitamin B12 Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vitamin B12 Market.

Available Customizations

Global Vitamin B12 Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Vitamin B12 Market

5. Global Vitamin B12 Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Pharmaceutical, Animal Feed, Food & Beverages, Healthcare, Personal Care, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Vitamin B12 Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Vitamin B12 Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Vitamin B12 Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Vitamin B12 Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Vitamin B12 Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Vitamin B12 Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Vitamin B12 Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Vitamin B12 Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Vitamin B12 Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Vitamin B12 Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Vitamin B12 Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Vitamin B12 Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Vitamin B12 Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Vitamin B12 Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Vitamin B12 Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Vitamin B12 Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Vitamin B12 Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Vitamin B12 Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Vitamin B12 Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Vitamin B12 Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Vitamin B12 Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Vitamin B12 Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Vitamin B12 Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Vitamin B12 Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Vitamin B12 Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hebei Yuxing Bio-Engineering Co., Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Hebei Huarong Pharmaceutical Co., Ltd
  • 15.3. North China Pharmaceutical Group Corp. (NCPC)
  • 15.4. Ningxia Kingvit Pharmaceutical CO.,LTD
  • 15.5. Euroapi
  • 15.6. DSM

16. Strategic Recommendations

17. About Us & Disclaimer